Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2

<b>Background:</b> Several pre-clinical and clinical reports suggest that HIV-1 protease inhibitors, in addition to the antiretroviral properties, possess pleiotropic pharmacological effects including anticancer action. Therefore, we investigated the pro-apoptotic activity in tumor cells...

Full description

Bibliographic Details
Main Authors: Roberta Rinaldi, Rocchina Miglionico, Ilaria Nigro, Rosarita D’Orsi, Lucia Chiummiento, Maria Funicello, Paolo Lupattelli, Ilaria Laurenzana, Alessandro Sgambato, Magnus Monné, Faustino Bisaccia, Maria Francesca Armentano
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
HIV-1 protease inhibitors
apoptosis
ER stress
UPR
proteasome
autophagy
Online Access:https://www.mdpi.com/2073-4409/10/11/3052

Internet

https://www.mdpi.com/2073-4409/10/11/3052

Similar Items